Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease
Cheng Zhu, Qian Huai, Xu Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 311-330
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver
Aleksandra Gruevska, Jack Leslie, Eunkyung An, et al.
Metabolism (2025), pp. 156237-156237
Open Access | Times Cited: 2
Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy
Hiroyuki Nojima, Hiroaki Shimizu, Takashi Murakami, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 850-850
Open Access | Times Cited: 8
Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis
Samaneh Siapoush, Ramazan Rezaei, Helia Alavifard, et al.
Life Sciences (2023) Vol. 329, pp. 121894-121894
Closed Access | Times Cited: 19
From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria
Ricardo Amorim, Carina C. Magalhães, Fernanda Borges, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 595-595
Open Access | Times Cited: 17
Cadmium exacerbates liver injury by remodeling ceramide metabolism: Multiomics and laboratory evidence
Danna Xie, Jun Yan, Honglong Zhang, et al.
The Science of The Total Environment (2024) Vol. 923, pp. 171405-171405
Closed Access | Times Cited: 6
Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis
Bruno Ramos‐Molina, Joana Rossell, Alejandra Pérez-Montes de, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals
Leila Mobasheri, Mitra Ahadi, Ali Beheshti Namdar, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115502-115502
Open Access | Times Cited: 11
Dietary sphingolipids and milk fat globule membrane: emerging roles in cardiometabolic health and muscle function
D.H. Park, H. S. Kim, Hee Hyun Shin, et al.
Food Science and Biotechnology (2025)
Closed Access
Coffee peel polyphenols ameliorate nonalcoholic fatty liver disease by modulating cannabinoid receptor type‐1‐ceramide axis
Zekai Fan, Yanfang Chen, Wei Han, et al.
Phytotherapy Research (2025)
Closed Access
Ceramide homeostasis in hepatic lipid droplets
Leobarda Robles‐Martínez, Kylie H. Morin, Mariana Nikolova‐Karakashian
Biochemical Society Transactions (2025) Vol. 53, Iss. 02, pp. 509-518
Open Access
When ceramides meet immune senescence, a GIMAP5 connection
Atrayee Gope, Claudio Mauro
Nature Immunology (2024) Vol. 25, Iss. 2, pp. 196-197
Closed Access | Times Cited: 2
Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease
Jiayi Zhang, Lingfang Wang, Meixiu Jiang
Medicine (2024) Vol. 103, Iss. 8, pp. e37185-e37185
Open Access | Times Cited: 2
Amitriptyline inhibits NLRP3 inflammasome activation via the ASM/CE pathway in a cell model of NAFLD
Qin Liu, Chun-Yan Niu, QIANG ZHANG, et al.
Biocell (2024) Vol. 48, Iss. 5, pp. 759-769
Open Access | Times Cited: 2
Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity
Achuthan Sourianarayanane, Christopher R. Brydges, Arthur J. McCullough
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102402-102402
Closed Access | Times Cited: 2
Glycosphingolipids: From metabolism to chemoenzymatic total synthesis
Mitra K. F. Bonab, Zhongwu Guo, Qingjiang Li
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 33, pp. 6665-6683
Open Access | Times Cited: 2
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
Damien Denimal, Sarah Béland-Bonenfant, Jean-Paul Pais-de-Barros, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Experimental Data on the Role of Melatonin in the Pathogenesis of Nonalcoholic Fatty Liver Disease
D. Terziev, D. Terzieva
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1722-1722
Open Access | Times Cited: 5
Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH)
Natsuko Hada, Asao Katsume, Kenichi Kawasaki, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 4
Microfluidic 3D hepatic cultures integrated with a droplet-based bioanalysis unit
José M. de Hoyos‐Vega, Alan M. Gonzalez‐Suarez, Diana F. Cedillo‐Alcantar, et al.
Biosensors and Bioelectronics (2023) Vol. 248, pp. 115896-115896
Closed Access | Times Cited: 4
Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolism in a 3D in vitro model of the human liver
Riju Roy Chowdhury, M Grosso, Darshak Gadara, et al.
Chemico-Biological Interactions (2024) Vol. 397, pp. 111046-111046
Open Access | Times Cited: 1
Effect of Hepatic Lipid Overload on Accelerated Hepatocyte Proliferation Promoted by HGF Expression via the SphK1/S1PR2 Pathway in MCD-diet Mouse Partial Hepatectomy
Baljinnyam Lkham-Erdene, Narantsog Choijookhuu, Toshiki Kubota, et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2024) Vol. 57, Iss. 5, pp. 175-188
Open Access | Times Cited: 1
Role of dietary and nutritional interventions in ceramide-associated diseases
Shengnan Wang, Zihui Jin, Biyu Wu, et al.
Journal of Lipid Research (2024), pp. 100726-100726
Closed Access | Times Cited: 1
A lipidomic approach to bisphenol F-induced non-alcoholic fatty liver disease-like changes: altered lipid components in a murine model
Xinjing Wang, Linlin Wu, Jingxian Tao, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 52, pp. 112644-112659
Closed Access | Times Cited: 2
The potential serum sphingolipid biomarkers for distinguishing Wilson disease
Shan Tang, Liang Chen, Haitian Yu, et al.
Clinica Chimica Acta (2023) Vol. 553, pp. 117740-117740
Closed Access | Times Cited: 2
Dysregulation of sphingolipid metabolism in liver fibrosis
Nan Wu, Meiyi Song, Fan Zhang, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top